Thema
rucaparib
317
Journal Article
303
8237F3U7EH
226
Indoles
216
Poly(ADP-ribose) Polymerase Inhibitors
216
Research Support, Non-U.S. Gov't
123
olaparib
120
Rucaparib
112
Review
90
niraparib
87
PARP inhibitor
70
Antineoplastic Agents
68
EC 2.4.2.30
65
Piperazines
60
PARP inhibitors
59
Phthalazines
59
WOH1JD9AR8
59
ovarian cancer
55
BRCA1 Protein
53
Poly(ADP-ribose) Polymerases
47
BRCA2 Protein
45
BRCA1 protein, human
41
talazoparib
40
Olaparib
39
Research Support, N.I.H., Extramural
38
BRCA2 protein, human
35
Piperidines
34
veliparib
34
Niraparib
32
Indazoles
31
HMC2H89N35
30
Poly (ADP-Ribose) Polymerase-1
29
PARP
28
BRCA
26
Ovarian cancer
26
Research Support, U.S. Gov't, Non-P.H.S.
21
Clinical Trial, Phase II
20
PARP1 protein, human
20
Comment
19
Multicenter Study
16
Clinical Trial, Phase I
15
Veliparib
15
9QHX048FRV
14
Benzimidazoles
14
01O4K0631N
13
DNA repair
13
EC 2.7.11.1
13
Randomized Controlled Trial
13
prostate cancer
13
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
12
mehr ...